Profile
Full Name
Myriad Genetics, Inc.Ticker Symbol
MYGNExchange
NASDAQSector
HealthcareIndustry
Diagnostics & ResearchCountry
United StatesIPO
October 6, 1995Indexes
Not includedWebsite
http://www.myriad.comEmployees
2700Key Details
Price
$7.64(-3.41%)
Market cap
$697.60M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$837.60M(+11.21% YoY)
Annual EPS
-$1.41(+55.66% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Myriad Genetics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 9, 25 Guggenheim
NeutralApr 1, 25 Scotiabank
Sector OutperformMar 12, 25 Piper Sandler
OverweightMar 4, 25 Piper Sandler
NeutralMar 3, 25 B of A Securities
UnderperformFeb 25, 25 UBS
NeutralFeb 25, 25 Raymond James
OutperformFeb 12, 25 Craig-Hallum
BuyJan 30, 25 Piper Sandler
NeutralJan 28, 25 Goldman Sachs
BuyInstitutional Ownership
- What is the ticker symbol for Myriad Genetics?
- Does Myriad Genetics pay dividends?
- What sector is Myriad Genetics in?
- What industry is Myriad Genetics in?
- What country is Myriad Genetics based in?
- When did Myriad Genetics go public?
- Is Myriad Genetics in the S&P 500?
- Is Myriad Genetics in the NASDAQ 100?
- Is Myriad Genetics in the Dow Jones?
- When was Myriad Genetics's last earnings report?
- When does Myriad Genetics report earnings?
- Should I buy Myriad Genetics stock now?
What is the ticker symbol for Myriad Genetics?
The ticker symbol for Myriad Genetics is NASDAQ:MYGN
Does Myriad Genetics pay dividends?
No, Myriad Genetics does not pay dividends
What sector is Myriad Genetics in?
Myriad Genetics is in the Healthcare sector
What industry is Myriad Genetics in?
Myriad Genetics is in the Diagnostics & Research industry
What country is Myriad Genetics based in?
Myriad Genetics is headquartered in United States
When did Myriad Genetics go public?
Myriad Genetics's initial public offering (IPO) was on October 6, 1995
Is Myriad Genetics in the S&P 500?
No, Myriad Genetics is not included in the S&P 500 index
Is Myriad Genetics in the NASDAQ 100?
No, Myriad Genetics is not included in the NASDAQ 100 index
Is Myriad Genetics in the Dow Jones?
No, Myriad Genetics is not included in the Dow Jones index
When was Myriad Genetics's last earnings report?
Myriad Genetics's most recent earnings report was on Feb 24, 2025
When does Myriad Genetics report earnings?
The next expected earnings date for Myriad Genetics is May 7, 2025
Should I buy Myriad Genetics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions